검색어 : 통합검색[354.3]
총 1,991건 중 1,000건 출력
, 4/100 페이지
-
31
- Sumoylation of Vimentin <sub>354</sub> Is Associated with PIAS3 Inhibition of Glioma Cell Migration
- Wang, Liming; Zhang, Jian; Banerjee, Sipra; Barnes, Laura; Sajja, Venkateswara; Liu, Yiding; Guo, Baochuan; Du, Yuping; Agarwal, Mukesh K.; Wald, David N.; Wang, Qin; Yang, Jinbo; School of Life Science, Lanzhou University, Lanzhou, P. R. China; Tartis, Inc., Buffalo, USA; Department of Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, USA; Molecular Genetics, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, USA; Molecular Genetics, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, USA; Department of Chemistry, Cleveland State University, Cleveland, USA; Department of Chemistry, Cleveland State University, Cleveland, USA; School of Life Science, Lanzhou University, Lanzhou, P. R. China; Invenio Therapeutics, Inc., Cleveland, USA; Department of Pathology, Case Western Reserve University, Cleveland, USA; School of Life Science, Lanzhou University, Lanzhou, P. R. China; School of Life Science, Lanzhou University, Lanzhou, P. R. China; (Oncotarget, v.1, 2010, pp.620-627)
-
32
- The 5-HT<sub>3</sub> receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats
- Dukat, M.; Wesolowska, A.; Young, R.; Glennon, R.A.; Department of Medicinal Chemistry School of Pharmacy Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0540, United States; (Pharmacology, biochemistry, and behavior, v.87, 2007, pp.203-207)
-
33
- 354 3D Images of the Ossicular chain abnormality with variable thresh-old value
- Sakata, M; Saoth, J; Kamagata, M; Sawaishi, M; ; (日本放射線技術學會雜誌 = Japanese journal of radiological technology, v.53, 1997, pp.1226)
-
34
- P3-354 : Post-translational modifications in Aβ and non-Aβ cerebral amyloidosis
- Ghiso, Jorge A.; Tomidokoro, Yasushi; Lashley, Tammaryn; Holton, Janice; Revesz, Tamas; Rostagno, Agueda; Frangione, Blas; ; (Alzheimer's & dementia : the journal of the Alzheimer's Association, v.2, 2006, pp.S479-S479)
-
35
- MD-354 : A NEW 5-HT3 AGONIST AS TRAINING DRUG IN DRUG DISCRIMINATION STUDIES
- Dukat, M.; Young, R.; Glennon, R. A.; ; (Behavioural pharmacology, v.9, 1998, pp.S108)
-
36
- Poster: MPN-354 Characteristics of Patients With Myelofibrosis Taking Ruxolitinib for 3 or More Years
- Masarova, Lucia; Bose, Prithviraj; Pemmaraju, Naveen; Kantarjian, Hagop; Estrov, Zeev; Verstovsek, Srdan; ; (Clinical lymphoma, myeloma & leukemia, v.22, 2022, pp.S158)
-
37
- Comparison of Techniques for Measurement of Brain Volume in Multiple Sclerosis Patients (P3.354)
- Tsang, Adrian; Wager, Carrie; Corredor-Jerez, Ricardo; Fartaria, Mario J.; Marechal, Benedicte; Kober, Tobias; Bermel, Robert; Jones, Stephen E.; Izbudak, Izlem; Lui, Yvonne W.; Krupp, Lauren; Mowry, Ellen M.; de Moor, Carl; Rudick, Richard A.; Williams, James R.; Fisher, Elizabeth; Biogen Cambridge MA United States; Biogen Cambridge MA United States; Siemens Healthcare AG Lausanne Switzerland; Siemens Healthcare AG Lausanne Switzerland; Siemens Healthcare AG Lausanne Switzerland; Siemens Healthcare AG Lausanne Switzerland; Cleveland Clinic Cleveland OH United States; Cleveland Clinic Cleveland OH United States; Johns Hopkins University Baltimore MD United States; New York University New York NY United States; New York University New York NY United States; Johns Hopkins University Baltimore MD United States; Biogen Cambridge MA United States; Biogen Cambridge MA United States; Biogen Cambridge MA United States; Biogen Cambridge MA United States; (Neurology, v.90, 2018, pp.P3.354)
-
38
- Ermittlung der Vergleichsmiete durch Sachverständigen : BGH, Urt. v. 3. 7. 2013 - VIII ZR 354/12
- Hinz, Vorsitzender Richter am LG Dr. Werner; Itzehoe; (Juristische Rundschau, v.2015, 2015, pp.73-79)
-
39
- MD-354 : A NEW 5-HT3 AGONIST AS TRAINING DRUG IN DRUG DISCRIMINATION STUDIES
- Dukat, M.; Young, R.; Glennon, R. A.; ; (Behavioural pharmacology, v.9, 1998, pp.S108)
-
40
- Bt354 as a new STAT3 signaling pathway inhibitor against triple negative breast cancer
- Chen, Yue; Ji, Ming; Zhang, Shen; Xue, Nina; Xu, Heng; Lin, Songwen; Chen, Xiaoguang; State Key laboratory of Bioactive Substances and Functions of Natural Medicines, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; State Key laboratory of Bioactive Substances and Functions of Natural Medicines, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; State Key laboratory of Bioactive Substances and Functions of Natural Medicines, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; State Key laboratory of Bioactive Substances and Functions of Natural Medicines, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; State Key laboratory of Bioactive Substances and Functions of Natural Medicines, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; State Key laboratory of Bioactive Substances and Functions of Natural Medicines, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing,; (Journal of drug targeting, v.26, 2018, pp.920-930)
QUICK MENU
